SEED THERAPEUTICS
LIVE

Serial Number

99361623

Owner

SEED Therapeutics US, Inc.

Attorney

Ian W. Gillies

Filing Date

Aug 27, 2025

Add to watchlist:

No watchlists yet
View on USPTO

SEED THERAPEUTICS Trademark

Serial Number: 99361623

SEED THERAPEUTICS is a trademark filed by SEED Therapeutics US, Inc. on August 27, 2025. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

SEED Therapeutics US, Inc. (4 trademarks)

411 Swedeland Road
King of Prussia, PA 19406

Entity Type: 03

Trademark Details

Filing Date

August 27, 2025

Registration Date

Not Registered

Published for Opposition

July 28, 2026

Goods & Services

Drug discovery and pharmaceutical drug development services; Drug validation services, namely, scientifically demonstrating that a new molecular entity has the potential to achieve, or achieves an acceptable balance of benefit to the patients versus side effects; Pharmaceutical research and development; providing medical research and scientific information in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; providing scientific, pharmaceutical, clinical research and medical research information about pharmaceutical drug development via the internet; consulting services in the fields of pharmaceuticals research, biology research, chemistry, biochemistry, scientific biotechnology research, and design, planning, and implementation of clinical trials; research and development of new products; scientific, research and development services; medical research services; Providing information about medical and scientific research relating to the identification of ubiquitin ligases for the purposes of degrading a disease-causing protein; scientific consultancy services in the field of identifying ubiquitin ligases for the purposes of degrading a disease-causing protein; Providing information about medical and scientific research with respect to using a photocatalyst molecule for labeling a protein proximate to a target disease-causing protein within a live cell; scientific consultancy services in the field of using a photocatalyst molecule for labeling a protein proximate to a target disease-causing protein within a live cell

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 28, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jul 28, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 22, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 1, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 24, 2026 XAEC
ASSIGNED TO LIE
Jun 23, 2026 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 22, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 22, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 22, 2026 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
May 21, 2026 GNFN
FINAL REFUSAL E-MAILED
May 21, 2026 GNFR
FINAL REFUSAL WRITTEN
May 21, 2026 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 24, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 24, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 24, 2026 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 20, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 20, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 21, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jan 21, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jan 21, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 13, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 27, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 27, 2025 NWOS
NEW APPLICATION ENTERED
Aug 27, 2025 NWAP